Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123552784 | 12355278 | 4 | F | 20140923 | 20160708 | 20160511 | 20160715 | EXP | PHEH2016US011512 | NOVARTIS | 37.12 | YR | M | Y | 85.26000 | KG | 20160716 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123552784 | 12355278 | 1 | PS | TASIGNA | NILOTINIB | 1 | Oral | 400 MG, BID | 22068 | 400 | MG | CAPSULE | BID | ||||||
| 123552784 | 12355278 | 2 | SS | DASATINIB | DASATINIB | 1 | Oral | 100 MG, QD | 0 | 100 | MG | QD | |||||||
| 123552784 | 12355278 | 3 | C | PRILOSEC | OMEPRAZOLE MAGNESIUM | 1 | Oral | 40 MG, QD | U | 0 | 40 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123552784 | 12355278 | 1 | Chronic myeloid leukaemia |
| 123552784 | 12355278 | 2 | Product used for unknown indication |
| 123552784 | 12355278 | 3 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123552784 | 12355278 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123552784 | 12355278 | Abdominal pain | |
| 123552784 | 12355278 | Abdominal pain upper | |
| 123552784 | 12355278 | Anxiety | |
| 123552784 | 12355278 | Appendicitis | |
| 123552784 | 12355278 | Arthralgia | |
| 123552784 | 12355278 | Arthritis | |
| 123552784 | 12355278 | Asthenia | |
| 123552784 | 12355278 | Blood pressure decreased | |
| 123552784 | 12355278 | Blood pressure increased | |
| 123552784 | 12355278 | Bone pain | |
| 123552784 | 12355278 | Decreased appetite | |
| 123552784 | 12355278 | Discomfort | |
| 123552784 | 12355278 | Dyspepsia | |
| 123552784 | 12355278 | Fatigue | |
| 123552784 | 12355278 | Hypersomnia | |
| 123552784 | 12355278 | Hypertrophy | |
| 123552784 | 12355278 | Intervertebral disc protrusion | |
| 123552784 | 12355278 | Leukocytosis | |
| 123552784 | 12355278 | Malaise | |
| 123552784 | 12355278 | Movement disorder | |
| 123552784 | 12355278 | Musculoskeletal stiffness | |
| 123552784 | 12355278 | Myalgia | |
| 123552784 | 12355278 | Pain | |
| 123552784 | 12355278 | Pain in extremity | |
| 123552784 | 12355278 | Spinal column stenosis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123552784 | 12355278 | 2 | 201405 | 0 |